Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Treatment for Chlamydia and Bacterial Vaginosis Co-infection

Treatment Regimen for Chlamydia

  • The Centers for Disease Control and Prevention recommends azithromycin 1g orally in a single dose or doxycycline 100mg orally twice daily for 7 days for chlamydia treatment, with azithromycin offering the advantage of single-dose therapy and directly observed treatment, which can improve compliance 1, 2
  • Doxycycline is equally efficacious as azithromycin, with 97-98% cure rates, and is a lower-cost alternative 1, 2

Treatment Regimen for Bacterial Vaginosis

  • No cited facts are available for the treatment of bacterial vaginosis.

Special Considerations

  • In pregnancy, azithromycin 1g orally in a single dose or amoxicillin 500mg orally three times daily for 7 days can be used for chlamydia treatment, while doxycycline and ofloxacin are contraindicated 2
  • Patients with HIV infection should receive the same treatment regimens as those without HIV 3

Management of Sex Partners

  • The Centers for Disease Control and Prevention recommends that all sexual partners within the previous 60 days should be referred for evaluation and treatment, and partners should receive the same treatment as the index patient 1, 2
  • Both patients and partners should abstain from sexual intercourse until 7 days after completing a single-dose regimen or until completion of a 7-day regimen 1, 2

Follow-Up Recommendations

  • Patients treated with azithromycin or doxycycline for chlamydia generally do not require retesting unless symptoms persist or reinfection is suspected, and retesting women approximately 3 months after treatment may be considered due to high risk of reinfection 1, 2
  • If symptoms persist, patients should return for reevaluation to assess for possible reexposure, partner treatment compliance, and other potential causes of symptoms 2

Common Pitfalls and Caveats

  • Failure to treat sexual partners is a common cause of reinfection, and medications for chlamydial infections should ideally be dispensed on-site, with the first dose directly observed to maximize compliance 1, 2

REFERENCES

2

Chlamydia Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Treatment of Ureaplasma STD in Women [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025